Post‑grant Patent Opposition in Malaysia (2026): a Practitioner's Guide

Post‑grant patent opposition in Malaysia became a live strategic tool on 31 December 2025, when the relevant provisions of the Patents (Amendment) Act and their accompanying regulations entered into force. For the first time, any person may now challenge a granted Malaysian patent through an administrative proceeding before the Registrar of Patents at MyIPO, without needing to demonstrate that they are directly affected by the patent in question. The reform aligns Malaysia with the broader ASEAN IP Rights Action Plan 2026–2030 objective of providing faster, lower‑cost validity mechanisms across the region.

For in‑house counsel, IP managers and M&A teams, the immediate implication is clear: every Malaysian patent granted on or after that date now carries a six‑month vulnerability window that must be factored into portfolio strategy, licensing negotiations and transaction timelines.

TL;DR: If you manage Malaysian patents, whether as owner, licensee, challenger or acquirer, begin a focused portfolio audit now. The sections below walk through exactly how to oppose a patent in Malaysia, how to defend one, and how to price opposition risk into deals.

Quick Decision Checklist: Should You Oppose, Defend or Monitor?

Before diving into procedure, the threshold question for any stakeholder is whether active engagement with the new post grant opposition Malaysia regime is warranted, or whether a watching‑brief approach makes more commercial sense. The decision matrix below distils the key triggers.

When to Oppose

• Direct commercial threat. The granted patent covers a product you manufacture, import or intend to launch in Malaysia within the next 24 months.
• Strong prior art position. You have already identified published prior art, prior public use evidence or prosecution‑history admissions that materially undermine at least one independent claim.
• Cost‑benefit favourable. An administrative opposition before MyIPO is likely to be substantially faster and less expensive than High Court invalidation proceedings, making early challenge cost‑effective.
• Licence leverage. A pending or disputed licence negotiation can be reframed once an opposition is on the register, filing may create settlement leverage or renegotiation pressure.

When to Defend (Rights‑Holders)

• High‑value asset. The patent protects a core revenue stream, an in‑licensed technology or a key M&A asset.
• Claims well‑drafted. Independent claims have a clear inventive‑step narrative, strong support in the description and no obvious prior‑art vulnerabilities.
• Proactive claim mapping. You have already prepared claim charts and can respond to a Notice of Opposition within prescribed deadlines.

When to Monitor

• Indirect exposure only. The patent belongs to a competitor but does not currently restrict your freedom to operate.
• Uncertain evidence. Your prior‑art position is weak, speculative or incomplete, opposing prematurely could telegraph strategy and waste costs.
• Strategic patience. You prefer to let a third party file, intervene later or reserve your arguments for court proceedings if litigation becomes necessary.

Key takeaway: Opposition is not automatic, it should follow a structured cost‑benefit assessment. Industry observers expect that the most frequent early filers will be generic pharmaceutical manufacturers, electronics competitors and licensees seeking to renegotiate royalty terms.

Post‑Grant Patent Opposition at MyIPO: Who May File, When, and How

The patent opposition procedure Malaysia now follows is set out in the Patents (Amendment) Act read together with MyIPO Practice Notice No. 1/2025, published on 10 October 2025. This section provides the step‑by‑step procedural detail that challengers and rights‑holders need.

Who May File a Notice of Opposition

A MyIPO patent opposition may be filed by any person. Unlike some jurisdictions that require standing or proof of adverse effect, the Malaysian regime imposes no such threshold. This means competitors, licensees, academic institutions, industry associations and even individuals with no commercial interest may initiate proceedings. The practical effect is to create a broad‑access administrative validity mechanism, one that industry observers expect will be used strategically by competitors as well as by parties conducting patent due diligence Malaysia transactions.

The Six‑Month Opposition Window

The Notice of Opposition (NOO) must be filed within six months from the date of publication of the grant of the patent. This is a hard deadline: MyIPO Practice Notice No. 1/2025 confirms that late filings will not be accepted. Because the window runs from the publication date, not the grant date itself, practitioners must monitor the MyIPO Patent Gazette closely. Any delay in setting up publication alerts could result in the window closing before an opposition can be prepared.

Filing the Notice of Opposition, Forms, Fees and Filing Channel

The NOO is filed with the Patent Registration Office at MyIPO. Practice Notice No. 1/2025 specifies the procedure for filing applications or requests related to opposition proceedings. The following checklist captures the core requirements:

• Prescribed form. The opponent must use the form specified in the Practice Notice. Ensure the latest version is downloaded from the MyIPO website.
• Identification of the patent. Include the Malaysian patent number, the publication date of the grant and the name of the patent owner.
• Statement of grounds. The NOO must set out, in summary form, each ground of opposition relied upon and the material facts supporting each ground.
• Supporting evidence. Attach or identify the evidence (prior art documents, affidavits, expert reports) on which the opponent intends to rely.
• Filing fee. Pay the prescribed fee at the time of filing. Late or underpaid filings risk rejection.
• Signature. The NOO may be signed by any person or by a registered patent agent acting on the opponent’s behalf.

Filing may be made via MyIPO’s e‑filing portal or by postal submission to the Patent Registration Office. Given strict deadline enforcement, electronic filing with a confirmation receipt is the recommended channel.

Respondent’s Options After Receiving the NOO

Once the Registrar serves the NOO on the patent owner, the respondent typically has the following options:

1. File an answering statement. Contest the opposition on the merits, supported by counter‑evidence (claim charts, inventor declarations, expert reports).
2. Amend the claims. Request amendment of the patent specification to narrow claims and overcome the objection, subject to the Registrar’s approval.
3. Surrender the patent. If the opposition is well‑founded and defence is commercially unjustifiable, the owner may surrender the patent (in whole or in part) to limit ongoing costs.
4. Negotiate settlement. The parties may reach a consent outcome, such as a licensing arrangement or claim limitation, at any stage, subject to the Registrar’s procedural requirements.

Key takeaway: The six‑month window is absolute. Challengers should begin prior‑art searches and evidence preparation the moment a potentially problematic patent is published. Rights‑holders should have claim charts and response templates ready before any NOO is filed.

Patent Opposition Grounds Malaysia: Evidence and Technical Claim Strategy

The statutory grounds for opposing a patent under the Malaysian regime mirror the substantive patentability requirements of the Patents Act. An opponent may rely on any of the following grounds, and should pair each with the appropriate evidence type.

Statutory Grounds and Recommended Evidence

• Lack of novelty. The claimed invention was anticipated by prior art published or publicly available before the priority date. Evidence: prior art search reports, dated publications, patent family documents, product catalogues with publication dates, internet archive snapshots.
• Lack of inventive step (obviousness). The invention would have been obvious to a person skilled in the art at the priority date. Evidence: expert reports applying the problem‑solution approach or analogous analysis, teaching‑suggestion‑motivation chains, secondary indicia (commercial success, long‑felt need, failure of others).
• Insufficient disclosure. The specification does not disclose the invention clearly and completely enough for a skilled person to perform it. Evidence: expert affidavits demonstrating attempts to replicate the invention, identifying gaps in the description.
• Non‑patentable subject matter. The claims cover excluded subject matter (e.g., discoveries, scientific theories, mathematical methods, schemes, rules or methods for doing business, or methods for the treatment of the human or animal body). Evidence: claim construction analysis showing the claimed invention falls within an exclusion.
• Prior public use or oral disclosure. The invention was publicly used or orally disclosed in Malaysia before the filing or priority date. Evidence: witness affidavits, photographs, sales invoices, exhibition records with dates.
• Lack of industrial applicability. The invention cannot be made or used in any kind of industry. Evidence: expert testimony, failed replication data.

Drafting Evidence Bundles: Admissibility and Exhibit Strategy

Effective evidence presentation can be decisive. The following practical guidance reflects best practice for MyIPO patent opposition proceedings:

1. Exhibit numbering. Number exhibits sequentially (e.g., OPP‑1, OPP‑2…) and cross‑reference each exhibit in the statement of grounds. The Registrar needs a clean paper trail.
2. Affidavit evidence. Factual claims, especially those relating to prior public use, should be supported by sworn affidavits. Identify each deponent, their qualifications, and their first‑hand knowledge of the facts.
3. Expert reports. For technical grounds (inventive step, insufficiency), commission an expert report from a person demonstrably skilled in the relevant art. The report should explain the common general knowledge, analyse each relevant claim and state clear conclusions.
4. Foreign prosecution history and court decisions. These can be relevant evidence, particularly where a corresponding patent has been narrowed or revoked overseas. Include authenticated copies and, where necessary, certified translations. The weight the Registrar gives to foreign materials will vary, but a well‑presented foreign decision can be highly persuasive.
5. Date authentication. Every item of prior art must have a reliable publication or availability date that predates the priority date. Undated documents are a frequent weakness in opposition evidence.

Claim Attack Strategy: Independent vs Dependent Claims

A structured claim‑attack plan increases efficiency and persuasive impact:

• Target independent claims first. If an independent claim falls, all dependent claims depending on it collapse. Focus the strongest prior art on the broadest claims.
• Layer grounds. Where possible, argue both lack of novelty and obviousness in the alternative against the same claim. This forces the patent owner to defend on multiple fronts.
• Map dependent claims separately. Identify which dependent claims add genuinely limiting features and prepare specific prior art for each. This prevents the patent owner from retreating to a narrow dependent claim that survives the opposition unchallenged.

Key takeaway: The quality of evidence, not the quantity, determines outcomes. Begin with a professional prior‑art search, invest in properly drafted expert reports and present exhibits in a clean, cross‑referenced format that the Registrar can follow efficiently.

Patent Opposition Timeline at MyIPO: Key Dates, Fees and Sample Calendar

Understanding the patent opposition timeline MyIPO applies is essential for both challengers timing a filing and rights‑holders preparing defences. The table below maps the key legislative milestones that brought the system into existence.

Sample Procedural Calendar (Illustrative)

The following sample calendar illustrates a plausible opposition timeline from NOO filing through to the Registrar’s decision. Actual deadlines will be set by the Registrar on a case‑by‑case basis.

Industry observers expect that well‑prepared cases with limited evidence may conclude more quickly, while complex multi‑ground oppositions could extend beyond 18 months. Practitioners should factor possible extension requests into project planning.

Key takeaway: Diarise the publication date of every patent you are monitoring. File the NOO early within the six‑month window to preserve maximum tactical flexibility for evidence preparation and procedural steps.

Transactional Implications: Licences, M&A and Patent Due Diligence Malaysia

The introduction of post‑grant patent opposition in Malaysia fundamentally changes the risk calculus for any transaction involving Malaysian patent rights. Every patent granted on or after 31 December 2025 now carries an inherent window of vulnerability that buyers, licensees and investors must price into deal structures. Understanding and mitigating patent portfolio risk Malaysia is now a core component of intellectual property protection strategy.

Transaction Risk Matrix

Due Diligence Checklist for Target Patents

When conducting patent due diligence Malaysia, the following red flags should be investigated for every Malaysian patent in a target portfolio:

• Grant publication date. Is the patent still within the six‑month opposition window?
• Opposition filings. Has any NOO been filed? Check MyIPO records directly.
• Prosecution history. Were claims significantly narrowed during examination? Narrowed claims may signal vulnerability to further challenge.
• Foreign family status. Has a corresponding patent been opposed, limited or revoked in another jurisdiction (e.g., EPO, USPTO PTAB, JPO)?
• Licence or assignment register. Are there registered licences or security interests that could be affected by opposition or revocation?
• Known prior art. Has the seller disclosed all material prior art? Obtain a seller’s disclosure schedule.

Structuring Indemnities, Escrows and Representations

Deal documentation for transactions involving recently granted Malaysian patents should now routinely address opposition risk. Recommended provisions include:

• Validity representation. Seller represents that, to its knowledge, no grounds exist for opposition of the patent, and that all material prior art was cited during prosecution.
• Indemnity. Seller indemnifies buyer for costs and losses arising from any opposition filed within the six‑month window, including legal fees and any diminution in patent scope.
• Escrow. A portion of the purchase price is held in escrow until the opposition window expires or any pending opposition is resolved.
• Defence obligations. Specify which party controls the defence of any opposition, and allocate costs accordingly.

For guidance on cross‑border IP portfolio structuring, see our international intellectual property guide. Teams working on Malaysian M&A transactions may also wish to review Malaysia merger control and M&A 2026 for complementary regulatory context.

Key takeaway: No Malaysian patent acquisition or licensing deal should close without checking whether the target patent is still within its opposition window. Adjust deal mechanics, escrows, representations and indemnities, accordingly.

Post‑Grant Patent Opposition in Malaysia: Action Plans and Practical Templates

Challenger Checklist: How to Oppose a Patent in Malaysia

1. Identify the target patent. Confirm the Malaysian patent number, the publication date of grant and the remaining time within the six‑month opposition window.
2. Conduct a professional prior‑art search. Commission a novelty and obviousness search covering patent and non‑patent literature. Prioritise dated, published documents.
3. Select grounds of opposition. Map each identified prior‑art reference to one or more statutory grounds. Prepare a claim chart for every independent claim.
4. Prepare the NOO. Use the prescribed form; include a concise statement of grounds, a summary of material facts and an exhibit list cross‑referencing all evidence.
5. Commission expert evidence. For inventive‑step or insufficiency grounds, engage a qualified expert to prepare a written report.
6. File early. Submit the NOO via MyIPO e‑filing. Retain the electronic confirmation receipt as proof of filing date.
7. Budget and timeline. Prepare a cost estimate covering search fees, agent fees, expert fees and any hearing costs. Map the expected procedural calendar against business milestones.

Rights‑Holder Rapid Response Plan

1. Set up monitoring. Subscribe to MyIPO Patent Gazette alerts for all patents in your portfolio. Flag patents approaching or within the opposition window.
2. Pre‑prepare claim charts. For every high‑value patent, prepare a claim chart mapping claim elements to the specification and known prior art. This enables rapid response if an NOO is received.
3. Identify potential amendments. Consider whether claim narrowing (auxiliary requests) could overcome likely grounds of attack without materially reducing commercial value.
4. Prepare an evidence bank. Assemble inventor declarations, laboratory notebooks, development timelines and commercial‑success data that may be relevant to defending inventive step.
5. Engage counsel early. Retain a registered patent agent with opposition experience before an NOO lands, response deadlines are fixed and leave little room for delay.

When to Seek Interim Measures or Court Relief

The MyIPO opposition is an administrative proceeding. The Registrar does not have jurisdiction to grant injunctions or interim relief. If an opponent or rights‑holder needs urgent relief, such as an injunction to prevent market entry or to restrain infringement during opposition proceedings, a separate application to the Malaysian High Court is required. Industry observers expect that parallel court proceedings may become more common as parties use opposition strategically alongside enforcement actions.

Key takeaway: Preparation is the single greatest advantage in opposition proceedings. Both challengers and rights‑holders should invest in pre‑opposition groundwork, claim charts, prior‑art searches, evidence banks and procedural templates, well before the six‑month window opens or an NOO arrives.

Remedies, Outcomes and Appeal Routes

At the conclusion of the opposition, the Registrar may deliver one of several outcomes:

• Opposition rejected. The patent is maintained in its granted form. The opponent bears its own costs.
• Opposition upheld in full. The patent is revoked. The likely practical effect will be the removal of the patent from the register, extinguishing all rights conferred.
• Opposition upheld in part. The patent is maintained in amended form, claims may be narrowed or specific claims deleted. This is an increasingly common outcome in comparable jurisdictions.
• Consent outcome. The parties reach agreement (e.g., claim amendments, licensing terms) and the Registrar records the outcome.

A party dissatisfied with the Registrar’s decision may pursue a statutory appeal or judicial review before the Malaysian High Court. The appeal must be filed within the time limit prescribed by the Patents Act. Given the novelty of the regime, early indications suggest that the courts will approach appeals on opposition decisions with care, likely applying a deferential standard to the Registrar’s findings of fact while reviewing questions of law de novo.

Conclusion

Post‑grant patent opposition in Malaysia is now operational and reshaping the strategic landscape for patent owners, challengers and deal teams alike. Whether you need to challenge a competitor’s patent, defend a core asset or price opposition risk into a transaction, proactive preparation is essential. To discuss your position with a qualified IP practitioner, find an expert in Malaysia through our global lawyer directory.

Sources

1. MyIPO, Practice Notice No. 1/2025 (Patent Act 1983)
2. Lexology, Malaysia’s New Post‑Grant Patent Opposition System
3. Skrine, Practice Notice for Patent Prosecution: New Post‑Grant Opposition
4. Adnan Sundra & Low, Post‑Grant Patent Opposition in Malaysia
5. Pintas IP Group, Using Malaysia’s New Post‑Grant Patent Opposition Regime
6. Christopher Lee Ong, Patents (Amendment) Act Provisions on Post‑Grant Patent Opposition